CD4 and neoplasm: As CD4+T cells are highly heterogeneous, the Th2 subpopulation can counter the anti-tumor effect of Th1 subpopulation, and Treg cells possess the impact of inhibiting the proliferation of effector T cells and the secretion of immunosuppressive cytokines, thus instigating tumor cells to escape from immune surveillance [32].